Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for AgeX Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for AgeX Therapeutics, Inc. is AGE and it is traded on the NYSEARCA (NYSE Arca).

Should I buy or sell AgeX Therapeutics, Inc. Stock?
AgeX Therapeutics, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy AgeX Therapeutics, Inc. Stock?
AgeX Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AgeX Therapeutics, Inc. Stock.

What's the current price of AgeX Therapeutics, Inc. Stock?
As of the end of day on the May 14, 2024, the price of an AgeX Therapeutics, Inc. (AGE) share was $11.10.

What is the 52-week high and low for AgeX Therapeutics, Inc. Stock?
The 52-week high for AgeX Therapeutics, Inc. Stock is $22.32 and the 52-week low is $0.310.

What is the market capitalization of AgeX Therapeutics, Inc. Stock?
As of the May 14, 2024, the market capitalization of AgeX Therapeutics, Inc. is 27.758M.

When is the next earnings date for AgeX Therapeutics, Inc. ?
The upcoming earnings date for AgeX Therapeutics, Inc. is Aug 06, 2024.
Click to get the best stock tips daily for free!

About AgeX Therapeutics, Inc.

AgeX Therapeutics. AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as Type II adult-onset diabetes and obesity; and AGEX-VASC1, a cell-base... AGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT